Literature DB >> 32399806

Is COVID-19 a New Hematologic Disease?

Benjamin Debuc1, David M Smadja2,3.   

Abstract

SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies.

Entities:  

Keywords:  Coagulopathy; Covid-19; Cytokine; D-dimers; Inflammation; Lymphopenia; Mesenchymal stem cells; SARS-CoV-2; Stem cells; Thrombosis

Mesh:

Substances:

Year:  2021        PMID: 32399806      PMCID: PMC7217340          DOI: 10.1007/s12015-020-09987-4

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  51 in total

Review 1.  Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?

Authors:  M Z Ratajczak; M Kucia; T Jadczyk; N J Greco; W Wojakowski; M Tendera; J Ratajczak
Journal:  Leukemia       Date:  2011-12-19       Impact factor: 11.528

2.  The Interplay between CD27dull and CD27bright B Cells Ensures the Flexibility, Stability, and Resilience of Human B Cell Memory.

Authors:  Ola Grimsholm; Eva Piano Mortari; Alexey N Davydov; Mikhail Shugay; Anna S Obraztsova; Chiara Bocci; Emiliano Marasco; Valentina Marcellini; Alaitz Aranburu; Chiara Farroni; Domenico Alessandro Silvestris; Cristina Cristofoletti; Ezio Giorda; Marco Scarsella; Simona Cascioli; Sabina Barresi; Vassilios Lougaris; Alessandro Plebani; Caterina Cancrini; Andrea Finocchi; Viviana Moschese; Diletta Valentini; Cristina Vallone; Fabrizio Signore; Giovanni de Vincentiis; Salvatore Zaffina; Giandomenico Russo; Angela Gallo; Franco Locatelli; Alberto E Tozzi; Marco Tartaglia; Dmitriy M Chudakov; Rita Carsetti
Journal:  Cell Rep       Date:  2020-03-03       Impact factor: 9.423

3.  Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential.

Authors:  Coralie L Guerin; Xavier Loyer; José Vilar; Audrey Cras; Tristan Mirault; Pascale Gaussem; Jean-Sébastien Silvestre; David M Smadja
Journal:  Thromb Haemost       Date:  2015-01-22       Impact factor: 5.249

4.  Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung.

Authors:  Susannah H Kassmer; Huiyan Jin; Ping-Xia Zhang; Emanuela M Bruscia; Kartoosh Heydari; Joo-Hyeon Lee; Carla F Kim; Susannah H Kassmer; Diane S Krause; Diane Krouse
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

5.  Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension.

Authors:  Coralie L Guerin; Adeline Blandinières; Benjamin Planquette; Jean-Sébastien Silvestre; Dominique Israel-Biet; Olivier Sanchez; David M Smadja
Journal:  Stem Cell Rev Rep       Date:  2017-08       Impact factor: 5.739

Review 6.  Mesenchymal Stem Cells Beyond Regenerative Medicine.

Authors:  Riam Shammaa; Abed El-Hakim El-Kadiry; Jamilah Abusarah; Moutih Rafei
Journal:  Front Cell Dev Biol       Date:  2020-02-18

7.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 8.  Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.

Authors:  Ali Golchin; Ehsan Seyedjafari; Abdolreza Ardeshirylajimi
Journal:  Stem Cell Rev Rep       Date:  2020-06       Impact factor: 5.739

9.  A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia.

Authors:  Isabella Quinti; Vassilios Lougaris; Cinzia Milito; Francesco Cinetto; Antonio Pecoraro; Ivano Mezzaroma; Claudio Maria Mastroianni; Ombretta Turriziani; Maria Pia Bondioni; Matteo Filippini; Annarosa Soresina; Giuseppe Spadaro; Carlo Agostini; Rita Carsetti; Alessandro Plebani
Journal:  J Allergy Clin Immunol       Date:  2020-04-22       Impact factor: 10.793

10.  Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.

Authors:  Elia Bari; Ilaria Ferrarotti; Laura Saracino; Sara Perteghella; Maria Luisa Torre; Angelo Guido Corsico
Journal:  Cells       Date:  2020-04-09       Impact factor: 6.600

View more
  25 in total

Review 1.  Hematopoietic stem and progenitor cells directly participate in host immune response.

Authors:  Olusola Jumoke Daramola; Stephen Osasan; Hebah Ali; Perpetua Emeagi
Journal:  Am J Stem Cells       Date:  2021-06-15

2.  Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.

Authors:  Najmeh Kaffash Farkhad; Alireza Sedaghat; Hamidreza Reihani; Amir Adhami Moghadam; Ahmad Bagheri Moghadam; Nayereh Khadem Ghaebi; Mohammad Ali Khodadoust; Rashin Ganjali; Amir Reza Tafreshian; Jalil Tavakol-Afshari
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

Review 3.  Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health?

Authors:  Rachel da Silveira Gorman; Iffath Unissa Syed
Journal:  Med Sci (Basel)       Date:  2022-05-28

Review 4.  Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction.

Authors:  Rahnuma Ahmad; Mainul Haque
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 5.  The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.

Authors:  Matteo Paganini; Gerardo Bosco; Filippo A G Perozzo; Eva Kohlscheen; Regina Sonda; Franco Bassetto; Giacomo Garetto; Enrico M Camporesi; Stephen R Thom
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Coronary microvascular dysfunction pathophysiology in COVID-19.

Authors:  Jie Yin; Shaoshen Wang; Yang Liu; Junhong Chen; Dongye Li; Tongda Xu
Journal:  Microcirculation       Date:  2021-06-02       Impact factor: 2.679

Review 7.  The signal pathways and treatment of cytokine storm in COVID-19.

Authors:  Lan Yang; Xueru Xie; Zikun Tu; Jinrong Fu; Damo Xu; Yufeng Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-07-07

Review 8.  Hematological manifestations of SARS-CoV-2 in children.

Authors:  Chrysoula Kosmeri; Epameinondas Koumpis; Sophia Tsabouri; Ekaterini Siomou; Alexandros Makis
Journal:  Pediatr Blood Cancer       Date:  2020-10-03       Impact factor: 3.167

9.  Differential alterations in peripheral lymphocyte subsets in COVID-19 patients: upregulation of double-positive and double-negative T cells.

Authors:  Asmaa M Zahran; Zeinab Albadry M Zahran; Yasmeen H Mady; Essam Eldeen M O Mahran; Alaa Rashad; Ahmed Makboul; Khalid A Nasif; Aida A Abdelmaksoud; Omnia El-Badawy
Journal:  Multidiscip Respir Med       Date:  2021-06-10

Review 10.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.